PUNE, India — The CEO of the world's biggest vaccine maker, Serum Institute of India, said the company has bolstered its manufacturing ahead of launches over the next few years of shots against diseases like malaria and dengue by repurposing facilities used to make COVID-19 immunizations.
The company is in talks with other countries and governments to utilize those facilities in the event of future outbreaks, he said, but did not provide further details on the discussions.Poonawalla said Serum has capacity to manufacture 100 million doses of its malaria vaccine, and could scale up further depending on demand. It has already produced 25 million doses ahead of a launch in the coming months.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: